Mentoring in Patient-Oriented Addiction Research

描述（由申请人提供）：我是一名有执照的临床心理学家和马萨诸塞州总医院（MGH）成瘾恢复管理服务（ARMS）的主任，MGH-哈佛康复研究所的创始人和主任，以及成瘾医学中心（CAM）的副主任。我也是哈佛医学院（HMS）的精神病学副教授，美国心理协会成瘾部（第50部）的当选主席，以及APA的成员。自1995年以来，我一直在NIAAA资助的面向患者的成瘾研究（POAR）中合作，并自2006年以来一直作为NIAAA的首席研究员获得资助。2006年，我被要求帮助指导MGH CAM，并开始建立一个蓬勃发展的临床研究项目，并花费大量时间进行指导。我的研究重点是了解酒精使用障碍（AUD）患者在整个生命周期中的治疗反应、长期结果和行为改变机制。我目前担任一项NIAAA R01和一项R21拨款的首席研究员。我指导了一群越来越多的初级调查员。我们正在努力提高AUD患者的治疗效果和康复结果，以开发具有成本效益的方法，减轻相关的健康、经济和社会负担。我工作在一个丰富的临床研究环境，这是理想的培训初级教师在POA。然而，我没有得到任何机构对指导的支持，并且将需要减少指导

DESCRIPTION (provided by applicant): I am a licensed clinical psychologist and Director of the Massachusetts General Hospital (MGH) Addiction Recovery Management Service (ARMS), founder and director of the MGH-Harvard Recovery Research Institute, and Associate Director of the Center for Addiction Medicine (CAM). I am also an Associate Professor in Psychiatry at Harvard Medical School (HMS), President Elect of the American Psychological Association Division on Addiction (Division 50), and a fellow of APA. I have collaborated in NIAAA-sponsored patient-oriented addiction research (POAR) since 1995 and have been continuously funded as a Principal Investigator by NIAAA since 2006. In 2006, I was asked to help direct the MGH CAM and began building a thriving clinical research program and spending significant time mentoring. My research has focused on understanding treatment response, long-term outcomes, and mechanisms of behavior change across the lifespan for individuals suffering from alcohol use disorder (AUD). I currently serve as principal investigator (PI) for one NIAAA R01 and one R21 grant award. I mentor a growing group of junior investigators. We are working to enhance treatment effectiveness and recovery outcomes for individuals treated for AUD to develop cost-efficient approaches and lessen the related health, economic, and social burden. I work in a rich environment for clinical research, which is ideal for training junior faculty in POA. However, I receive no institutional support for mentoring and will be required to curtail mentoring efforts to assume significant clinical responsibilities beginning early 2013. The K24 award will protect time that would otherwise be diverted to clinical and administrative responsibilities to allow me to continue to provide intensive mentorship to junior investigators and attract researchers to POAR. My long term career objectives are: 1) To improve outcomes for individuals with AUD by developing, implementing, and evaluating novel treatment and recovery support service interventions; 2) To improve our knowledge about which types of treatment and recovery support combinations are needed for which patients during which recovery phases; 3) To understand systems and policy factors that may impede or facilitate the formation, implementation, and maintenance of effective recovery strategies; 4) To provide mentored research opportunities for early career investigators in POAR. The specific aims to be accomplished during the period of the award are to 1) Develop specific content expertise in treatment and recovery policy, and the design, implementation, and evaluation of treatment and recovery support service combinations; 2) Protect time for substantive mentoring of junior investigators in POAR, which will often take place within the context of funded research, such that more intensive mentorship will increase quality and output from ongoing POAR; and 3) Continue and extend involvement in POAR. The K24 will help me extend my POAR by protecting time that will facilitate work with mentees on funded projects, ancillary studies, secondary analyses, and papers and grants that will add value to ongoing POAR. I will devote 30% time to mentoring, 20% time to training, and 45% time to funded POAR.